A Study of Avutometinib and Defactinib in People With Thyroid Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Thyroid Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Alan Ho, MD. PhD) · 646-608-3774
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Alan Ho, MD, PhD) · 646-608-3774
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Alan Ho, MD, PhD) · 646-608-3774
  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Alan Ho, MD, PhD) · 646-608-3774
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Alan Ho, MD, PhD) · 646-608-3774
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Alan Ho, MD. PhD) · 646-608-3774
    Contact: Principal Investigator (Alan Ho, MD, PhD)
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre, New York, United States

    Contact: Study coordinator (Alan Ho, MD, PhD) · 646-608-3774
Study leads
  • Alan Ho, MD, PhD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center